Mapping the Implementation of a Clinical Pharmacist-Driven Antimicrobial Stewardship Programme at a Tertiary Care Centre in South India.

antimicrobial management antimicrobial resistance antimicrobial stewardship clinical pharmacist defined daily dose

Journal

Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404

Informations de publication

Date de publication:
23 Feb 2021
Historique:
received: 30 10 2020
revised: 01 01 2021
accepted: 05 01 2021
entrez: 6 3 2021
pubmed: 7 3 2021
medline: 7 3 2021
Statut: epublish

Résumé

In many parts of the world, including in India, pharmacist roles in antimicrobial stewardship (AMS) programmes remain unexplored. We describe the evolution and effect of the role of adding clinical pharmacists to a multidisciplinary AMS at a tertiary care teaching hospital in Kerala, India. Through effective leadership, multidisciplinary AMS (February 2016) and antitubercular therapy (ATT) stewardship programmes (June 2017) were established. Clinical pharmacists were introduced as core members of the programmes, responsible for the operational delivery of key stewardship interventions. Pharmacy-led audit and feedback monitored the appropriateness of antimicrobial prescriptions and compliance to AMS/ATT recommendations. Between February 2016 and January 2017, 56% (742/1326) of antimicrobial prescriptions were appropriate, and 54% (318/584) of recommendations showed compliance. By the third year of the AMS, appropriateness increased to 80% (1752/2190), and compliance to the AMS recommendations to 70% (227/325). The appropriateness of ATT prescriptions increased from a baseline of 61% (95/157) in the first year, to 72% (62/86, June 2018-February 2019). The compliance to ATT recommendations increased from 42% (25/60) to 58% (14/24). Such a model can be effective in implementing sustainable change in low- and middle-income countries (LMICs) such as India, where the shortage of infectious disease physicians is a major impediment to the implementation and sustainability of AMS programmes.

Identifiants

pubmed: 33672095
pii: antibiotics10020220
doi: 10.3390/antibiotics10020220
pmc: PMC7926893
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Expert Rev Anti Infect Ther. 2012 Jan;10(1):63-73
pubmed: 22149615
Clin Infect Dis. 2014 Oct 15;59 Suppl 3:S97-100
pubmed: 25261548
PLoS One. 2019 Jan 16;14(1):e0209847
pubmed: 30650099
Front Public Health. 2020 Apr 09;8:109
pubmed: 32328474
Expert Rev Anti Infect Ther. 2009 Dec;7(10):1175-83
pubmed: 19968511
Antimicrob Resist Infect Control. 2018 May 2;7:63
pubmed: 29744044
J Multidiscip Healthc. 2019 Nov 27;12:975-980
pubmed: 31819471
Int J Infect Dis. 2020 Nov;100:497-506
pubmed: 32781161
J Antimicrob Chemother. 2007 Aug;60 Suppl 1:i73-6
pubmed: 17656388
Indian J Med Res. 2019 Feb;149(2):180-184
pubmed: 31219081
Clin Microbiol Rev. 2005 Oct;18(4):638-56
pubmed: 16223951
Infect Control Hosp Epidemiol. 2009 Jan;30(1):97-8
pubmed: 19046053
Lancet Infect Dis. 2016 Sep;16(9):1017-1025
pubmed: 27312577
Infect Control Hosp Epidemiol. 2000 Jun;21(6):394-7
pubmed: 10879571
Proc Natl Acad Sci U S A. 2018 Apr 10;115(15):E3463-E3470
pubmed: 29581252
Clin Infect Dis. 2007 Jan 15;44(2):159-77
pubmed: 17173212
Public Health Action. 2018 Sep 21;8(3):151
pubmed: 30271733
Clin Infect Dis. 2018 Aug 16;67(5):799-801
pubmed: 29547995
Clin Infect Dis. 2016 May 15;62(10):1197-1202
pubmed: 27118828
Am J Health Syst Pharm. 2010 Apr 1;67(7):575-7
pubmed: 20237387
Open Forum Infect Dis. 2018 Nov 08;6(4):ofy290
pubmed: 31024967
J Am Pharm Assoc (2003). 2018 Sep - Oct;58(5):481-484
pubmed: 30007508
Med Clin North Am. 2018 Sep;102(5):929-936
pubmed: 30126581
Hosp Pharm. 2019 Aug;54(4):250-258
pubmed: 31320775
Int J Clin Pharm. 2018 Oct;40(5):948-952
pubmed: 30242589
Ther Adv Drug Saf. 2014 Dec;5(6):229-41
pubmed: 25436105
BMJ Open. 2019 May 14;9(5):e026193
pubmed: 31092653
Indian J Med Res. 2015 Aug;142(2):130-8
pubmed: 26354210

Auteurs

Vrinda Nampoothiri (V)

Department of Infection Control and Epidemiology, Amrita Institute of Medical Science, Amrita Vishwa Vidyapeetham, Kochi 682041, Kerala, India.

Akkulath Sangita Sudhir (AS)

Department of Infection Control and Epidemiology, Amrita Institute of Medical Science, Amrita Vishwa Vidyapeetham, Kochi 682041, Kerala, India.

Mariam Varsha Joseph (MV)

Department of Infection Control and Epidemiology, Amrita Institute of Medical Science, Amrita Vishwa Vidyapeetham, Kochi 682041, Kerala, India.

Zubair Mohamed (Z)

Anesthesiology and Critical Care Medicine, Amrita Institute of Medical Science, Amrita Vishwa Vidyapeetham, Kochi 682041, Kerala, India.

Vidya Menon (V)

Department of Medicine, Division of Infectious Diseases, Amrita Institute of Medical Science, Amrita Vishwa Vidyapeetham, Kochi 682041, Kerala, India.

Esmita Charani (E)

Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College, London W12 0NN, UK.

Sanjeev Singh (S)

Department of Infection Control and Epidemiology, Amrita Institute of Medical Science, Amrita Vishwa Vidyapeetham, Kochi 682041, Kerala, India.

Classifications MeSH